News Archive - School of Medicine

Blood Thinner Found to Significantly Reduce Subsequent Heart Failure Risks

Researchers at University of California San Diego School of Medicine found using blood thinners in patients with worsening heart failure, coronary artery disease and irregular heart rhythms was associated with a reduced risk of thromboembolic events, such as stroke and heart attack.

Exposing Cancer’s Metabolic Addictions

University of California San Diego School of Medicine researchers and collaborators describe a new set of “rules” that predict how the tissue of origin influences critical aspects of the genetic makeup of tumors, with potentially important therapeutic implications.

Personalizing Precision Medicine with Combination Therapies Improves Outcomes in Cancer

University of California San Diego School of Medicine researchers found that treating patients with personalized precision medicine that combined therapies to target multiple alterations improved outcomes in patients with therapy resistant cancers.

American Academy of Arts and Sciences Elects Three UC San Diego Professors

Susan Ackerman, Yishi Jin and John Wixted of UC San Diego have been elected to the American Academy of Arts and Sciences, one of the country’s most esteemed honorary societies and independent policy research centers. They will join 200 new members in the organization’s 2019 class.

Robotic Spine Surgery Program Expands at UC San Diego Health

UC San Diego Health has invested in a new robotic technology to benefit patients in need of restorative spine surgery. This technology enables minimally invasive spine surgery, the benefits of which include potential for shorter operations, less anesthesia, smaller incisions and reduced blood loss.

In Mice, Eliminating Damaged Mitochondria Alleviates Chronic Inflammatory Disease

Treatment with a choline kinase inhibitor prompts immune cells to clear away damaged mitochondria, thus reducing NLRP3 inflammasome activation and preventing inflammation

NASA Twin Study Provides a Multi-omics View of the Human Body’s Response to a Year in Space

The NASA Twins Study is the most comprehensive integrated multi-omics, molecular, physiological, and behavioral analysis of how the human body responds to space flight to date. Study results were published in the April edition of Science

Waiting with Ablated Breath: Is This the Cure for Ventricular Fibrillation?

Patients who suffer from VF live in constant fear of triggering a cardiac event, which can only be treated with an automated external defibrillator and which can become fatal in mere seconds. But a new procedure developed at UC San Diego Health is now presenting an alternative: a curative procedure.

Genome-Wide Analysis Reveals New Strategies to Target Pancreatic Cancer

An international team of scientists led by researchers at University of California San Diego School of Medicine employed an array of next-generation sequencing and gene-editing tools, such as CRISPR, to map the molecular dependencies – and thus vulnerabilities – of pancreatic cancer stem cells.

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

Moores Cancer Center at UC San Diego Health treats the first patient treated for cancer with a human-induced pluripotent stem cell (iPSC)-derived cell therapy called FT500. Dan Kaufman collaborated with Fate Therapeutics to bring the iPSC-derived natural killer cell cancer immunotherapy to patients.